Annual CFO
-$25.90 M
+$11.88 M+31.45%
December 31, 2022
Summary
- As of February 10, 2025, ADMP annual cash flow from operations is -$25.90 million, with the most recent change of +$11.88 million (+31.45%) on December 31, 2022.
- During the last 3 years, ADMP annual CFO has fallen by -$6.01 million (-30.25%).
Performance
ADMP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$2.57 M
-$1.02 M-65.98%
June 30, 2023
Summary
- As of February 10, 2025, ADMP quarterly cash flow from operations is -$2.57 million, with the most recent change of -$1.02 million (-65.98%) on June 30, 2023.
- Over the past year, ADMP quarterly CFO has increased by +$7.33 million (+74.04%).
Performance
ADMP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$13.14 M
+$7.33 M+35.80%
June 30, 2023
Summary
- As of February 10, 2025, ADMP TTM cash flow from operations is -$13.14 million, with the most recent change of +$7.33 million (+35.80%) on June 30, 2023.
- Over the past year, ADMP TTM CFO has increased by +$20.18 million (+60.58%).
Performance
ADMP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADMP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | +74.0% | +60.6% |
| 3 y3 years | -30.3% | +50.0% | +20.8% |
| 5 y5 years | -71.2% | +42.3% | +33.9% |
ADMP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.9% | +68.8% | +285.2% | at high | +206.3% |
| 5 y | 5-year | +30.2% | +45.9% | +68.8% | +554.4% | at high | +206.3% |
| alltime | all time | -1712.7% | +45.9% | -120.2% | +554.4% | -377.2% | +206.3% |
Adamis Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.57 M(+66.0%) | -$13.14 M(-35.8%) |
| Mar 2023 | - | -$1.55 M(+1.7%) | -$20.46 M(-21.0%) |
| Dec 2022 | -$25.90 M(-31.5%) | -$1.52 M(-79.7%) | -$25.90 M(-16.6%) |
| Sep 2022 | - | -$7.50 M(-24.2%) | -$31.05 M(-6.8%) |
| Jun 2022 | - | -$9.89 M(+41.6%) | -$33.32 M(-17.2%) |
| Mar 2022 | - | -$6.99 M(+4.7%) | -$40.23 M(+6.5%) |
| Dec 2021 | -$37.79 M(+80.8%) | -$6.67 M(-31.7%) | -$37.79 M(+3.5%) |
| Sep 2021 | - | -$9.77 M(-41.9%) | -$36.52 M(+11.1%) |
| Jun 2021 | - | -$16.81 M(+270.5%) | -$32.87 M(+55.0%) |
| Mar 2021 | - | -$4.54 M(-16.2%) | -$21.20 M(+1.4%) |
| Dec 2020 | -$20.90 M(+5.1%) | -$5.41 M(-11.4%) | -$20.90 M(+13.4%) |
| Sep 2020 | - | -$6.11 M(+18.9%) | -$18.43 M(+11.2%) |
| Jun 2020 | - | -$5.14 M(+21.2%) | -$16.58 M(+4.6%) |
| Mar 2020 | - | -$4.24 M(+44.3%) | -$15.85 M(-20.3%) |
| Dec 2019 | -$19.89 M(-39.1%) | -$2.94 M(-31.0%) | -$19.89 M(-32.0%) |
| Sep 2019 | - | -$4.26 M(-3.6%) | -$29.22 M(-11.3%) |
| Jun 2019 | - | -$4.42 M(-46.6%) | -$32.95 M(-0.1%) |
| Mar 2019 | - | -$8.27 M(-32.6%) | -$32.98 M(+1.0%) |
| Dec 2018 | -$32.66 M(+115.8%) | -$12.28 M(+53.8%) | -$32.66 M(+27.4%) |
| Sep 2018 | - | -$7.98 M(+79.3%) | -$25.63 M(+24.7%) |
| Jun 2018 | - | -$4.45 M(-44.0%) | -$20.55 M(+5.0%) |
| Mar 2018 | - | -$7.95 M(+51.5%) | -$19.57 M(+29.3%) |
| Dec 2017 | -$15.13 M(-28.5%) | -$5.25 M(+80.7%) | -$15.13 M(+14.9%) |
| Sep 2017 | - | -$2.90 M(-16.4%) | -$13.17 M(-22.6%) |
| Jun 2017 | - | -$3.47 M(-1.0%) | -$17.01 M(-14.9%) |
| Mar 2017 | - | -$3.51 M(+6.8%) | -$20.00 M(-5.5%) |
| Dec 2016 | -$21.16 M(+104.7%) | -$3.29 M(-51.3%) | -$21.16 M(+5.3%) |
| Sep 2016 | - | -$6.74 M(+4.3%) | -$20.10 M(+29.6%) |
| Jun 2016 | - | -$6.46 M(+38.4%) | -$15.51 M(+31.1%) |
| Mar 2016 | - | -$4.67 M(+109.5%) | -$11.83 M(+14.5%) |
| Dec 2015 | -$10.34 M(+61.2%) | -$2.23 M(+3.9%) | -$10.34 M(+27.5%) |
| Sep 2015 | - | -$2.15 M(-23.1%) | -$8.11 M(+12.4%) |
| Jun 2015 | - | -$2.79 M(-12.1%) | -$7.21 M(+1.9%) |
| Mar 2015 | - | -$3.17 M(+154.1%) | -$7.08 M(-18.7%) |
| Dec 2014 | -$6.41 M(-5.4%) | - | - |
| Sep 2014 | - | -$1.25 M(-53.0%) | -$8.70 M(+12.2%) |
| Jun 2014 | - | -$2.66 M(+13.5%) | -$7.76 M(+14.4%) |
| Mar 2014 | -$6.78 M(+165.0%) | -$2.34 M(-4.8%) | -$6.78 M(+52.1%) |
| Dec 2013 | - | -$2.46 M(+713.3%) | -$4.46 M(+70.9%) |
| Sep 2013 | - | -$302.20 K(-82.0%) | -$2.61 M(-13.5%) |
| Jun 2013 | - | -$1.68 M(+9611.0%) | -$3.02 M(+17.9%) |
| Mar 2013 | -$2.56 M(-23.5%) | -$17.30 K(-97.2%) | -$2.56 M(-19.7%) |
| Dec 2012 | - | -$608.70 K(-14.3%) | -$3.19 M(-3.0%) |
| Sep 2012 | - | -$710.00 K(-42.0%) | -$3.29 M(-2.3%) |
| Jun 2012 | - | -$1.22 M(+89.2%) | -$3.37 M(+0.6%) |
| Mar 2012 | -$3.35 M(-22.3%) | -$646.40 K(-8.8%) | -$3.35 M(-15.3%) |
| Dec 2011 | - | -$708.60 K(-10.1%) | -$3.95 M(-27.7%) |
| Sep 2011 | - | -$788.20 K(-34.5%) | -$5.46 M(+7.3%) |
| Jun 2011 | - | -$1.20 M(-3.7%) | -$5.09 M(+18.2%) |
| Mar 2011 | -$4.31 M(+115.5%) | -$1.25 M(-43.9%) | -$4.31 M(-1.1%) |
| Dec 2010 | - | -$2.22 M(+436.6%) | -$4.36 M(+66.8%) |
| Sep 2010 | - | -$414.60 K(-1.0%) | -$2.61 M(+21.1%) |
| Jun 2010 | - | -$418.90 K(-67.7%) | -$2.16 M(+7.9%) |
| Mar 2010 | -$2.00 M | -$1.30 M(+170.1%) | -$2.00 M(+161.2%) |
| Dec 2009 | - | -$480.50 K(-1292.3%) | -$765.10 K(+48.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $40.30 K(-115.4%) | -$516.10 K(-37.8%) |
| Jun 2009 | - | -$260.90 K(+307.7%) | -$830.40 K(-2.0%) |
| Mar 2009 | - | -$64.00 K(-72.4%) | -$847.50 K(-29.2%) |
| Dec 2008 | -$1.20 M(-38.2%) | -$231.50 K(-15.5%) | -$1.20 M(-6.0%) |
| Sep 2008 | - | -$274.00 K(-1.4%) | -$1.27 M(-8.1%) |
| Jun 2008 | - | -$278.00 K(-32.9%) | -$1.39 M(-19.7%) |
| Mar 2008 | - | -$414.00 K(+34.3%) | -$1.73 M(-10.9%) |
| Dec 2007 | -$1.94 M(-61.6%) | -$308.20 K(-20.2%) | -$1.94 M(-36.7%) |
| Sep 2007 | - | -$386.00 K(-37.5%) | -$3.06 M(-18.3%) |
| Jun 2007 | - | -$618.00 K(-1.1%) | -$3.75 M(-19.7%) |
| Mar 2007 | - | -$625.00 K(-56.4%) | -$4.67 M(-7.5%) |
| Dec 2006 | -$5.04 M(-69.9%) | -$1.43 M(+33.5%) | -$5.04 M(-38.1%) |
| Sep 2006 | - | -$1.07 M(-30.1%) | -$8.15 M(-7.7%) |
| Jun 2006 | - | -$1.54 M(+53.4%) | -$8.82 M(-31.5%) |
| Mar 2006 | - | -$1.00 M(-77.9%) | -$12.89 M(-22.9%) |
| Dec 2005 | -$16.73 M(+23.0%) | -$4.54 M(+159.3%) | -$16.73 M(-3.7%) |
| Sep 2005 | - | -$1.75 M(-68.8%) | -$17.37 M(-3.7%) |
| Jun 2005 | - | -$5.60 M(+15.7%) | -$18.04 M(+17.8%) |
| Mar 2005 | - | -$4.84 M(-6.6%) | -$15.31 M(+12.6%) |
| Dec 2004 | -$13.60 M(+8.7%) | -$5.18 M(+114.6%) | -$13.60 M(+21.9%) |
| Sep 2004 | - | -$2.42 M(-16.0%) | -$11.16 M(-5.5%) |
| Jun 2004 | - | -$2.88 M(-8.1%) | -$11.81 M(-3.8%) |
| Mar 2004 | - | -$3.13 M(+14.0%) | -$12.28 M(-1.8%) |
| Dec 2003 | -$12.51 M(-878.8%) | -$2.74 M(-10.4%) | -$12.51 M(-521.0%) |
| Sep 2003 | - | -$3.06 M(-8.3%) | $2.97 M(-37.3%) |
| Jun 2003 | - | -$3.34 M(-0.5%) | $4.74 M(+55.0%) |
| Mar 2003 | - | -$3.36 M(-126.4%) | $3.06 M(+90.3%) |
| Dec 2002 | $1.61 M(-112.3%) | $12.73 M(-1081.8%) | $1.61 M(-111.8%) |
| Sep 2002 | - | -$1.30 M(-74.2%) | -$13.66 M(-12.5%) |
| Jun 2002 | - | -$5.02 M(+4.5%) | -$15.62 M(+3.1%) |
| Mar 2002 | - | -$4.81 M(+89.8%) | -$15.14 M(+16.4%) |
| Dec 2001 | -$13.01 M(+41.7%) | -$2.53 M(-22.1%) | -$13.01 M(+1.0%) |
| Sep 2001 | - | -$3.25 M(-28.5%) | -$12.88 M(+4.4%) |
| Jun 2001 | - | -$4.55 M(+69.8%) | -$12.33 M(+18.1%) |
| Mar 2001 | - | -$2.68 M(+11.7%) | -$10.44 M(+13.6%) |
| Dec 2000 | -$9.18 M(-4.3%) | -$2.40 M(-11.3%) | -$9.18 M(+3.4%) |
| Sep 2000 | - | -$2.71 M(+1.9%) | -$8.88 M(+3.6%) |
| Jun 2000 | - | -$2.65 M(+86.3%) | -$8.57 M(+11.0%) |
| Mar 2000 | - | -$1.43 M(-32.1%) | -$7.72 M(-19.5%) |
| Dec 1999 | -$9.60 M(+33.3%) | -$2.10 M(-12.2%) | -$9.60 M(+6.7%) |
| Sep 1999 | - | -$2.39 M(+32.4%) | -$9.00 M(+8.3%) |
| Jun 1999 | - | -$1.81 M(-45.2%) | -$8.31 M(-4.5%) |
| Mar 1999 | - | -$3.30 M(+120.0%) | -$8.70 M(+20.8%) |
| Dec 1998 | -$7.20 M(+105.7%) | -$1.50 M(-11.8%) | -$7.20 M(+1.4%) |
| Sep 1998 | - | -$1.70 M(-22.7%) | -$7.10 M(+22.4%) |
| Jun 1998 | - | -$2.20 M(+22.2%) | -$5.80 M(+31.8%) |
| Mar 1998 | - | -$1.80 M(+28.6%) | -$4.40 M(+25.7%) |
| Dec 1997 | -$3.50 M(+6.1%) | -$1.40 M(+250.0%) | -$3.50 M(+52.2%) |
| Sep 1997 | - | -$400.00 K(-50.0%) | -$2.30 M(-25.8%) |
| Jun 1997 | - | -$800.00 K(-11.1%) | -$3.10 M(0.0%) |
| Mar 1997 | - | -$900.00 K(+350.0%) | -$3.10 M(-6.1%) |
| Dec 1996 | -$3.30 M(+22.2%) | -$200.00 K(-83.3%) | -$3.30 M(+6.5%) |
| Sep 1996 | - | -$1.20 M(+50.0%) | -$3.10 M(+63.2%) |
| Jun 1996 | - | -$800.00 K(-27.3%) | -$1.90 M(+72.7%) |
| Mar 1996 | - | -$1.10 M | -$1.10 M |
| Dec 1995 | -$2.70 M | - | - |
FAQ
- What is Adamis Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual CFO year-on-year change?
- What is Adamis Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly CFO year-on-year change?
- What is Adamis Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals TTM CFO year-on-year change?
What is Adamis Pharmaceuticals annual cash flow from operations?
The current annual CFO of ADMP is -$25.90 M
What is the all time high annual CFO for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual cash flow from operations is $1.61 M
What is Adamis Pharmaceuticals annual CFO year-on-year change?
Over the past year, ADMP annual cash flow from operations has changed by +$11.88 M (+31.45%)
What is Adamis Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ADMP is -$2.57 M
What is the all time high quarterly CFO for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly cash flow from operations is $12.73 M
What is Adamis Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ADMP quarterly cash flow from operations has changed by +$7.33 M (+74.04%)
What is Adamis Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ADMP is -$13.14 M
What is the all time high TTM CFO for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high TTM cash flow from operations is $4.74 M
What is Adamis Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ADMP TTM cash flow from operations has changed by +$20.18 M (+60.58%)